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S U M M A R Y
Background: Nutritionally variant streptococci (NVS) are Gram-positive cocci characterized by their
dependence on pyridoxal or cysteine supplementation for growth in standard blood culture media. They
are responsible for severe infections in immunocompetent and immunosuppressed hosts, including
infective endocarditis (IE). NVS have been divided into two different genera, Granulicatella and Abiotrophia.
Methods: We report four cases of IE caused by Granulicatella species, including clinical presentation,
echocardiographic characteristics, treatments received, and outcomes. We also performed a literature
search for previously reported cases of IE caused by Granulicatella species to better characterize this
condition.
Results: A total of 29 cases of Granulicatella endocarditis were analyzed, including the four newly
reported cases. The aortic (44%) and mitral (38%) valves were those most commonly affected.
Multivalvular involvement was observed in 13% of cases. The mean vegetation length was 16 mm.
Complications were frequent, including heart failure (30%), embolism (30%), and perivalvular abscess
(11%). The most frequent antibiotic regimen (85%) was penicillin or one of its derivatives plus
gentamicin. The mortality rate was 17%.
Conclusions: Endocarditis due to Granulicatella species is a rare and severe condition. Complications are
frequent despite the use of appropriate antibiotic regimens.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Nutritionally variant streptococci (NVS) were ﬁrst described in
1961 by Frenkel and Hirsch as fastidious organisms that showed
satellitism around colonies of other bacteria.1 These Gram-positive
cocci were characterized by their dependence on pyridoxal or
cysteine supplementation for growth in standard blood culture
media. Although part of the normal oral, gastrointestinal, and
genitourinary microbiota, NVS can cause severe infections in both
immunocompetent and immunosuppressed hosts. NVS are also
described as a cause of culture-negative infective endocarditis (IE),
due to their slow growth and requirement for special media for
identiﬁcation. Other conditions related to NVS include primary
bloodstream infections in neutropenic patients, central nervous
system infections, osteomyelitis, septic arthritis, chronic sinusitis,
and endophthalmitis.* Corresponding author. Tel.: +55 11 982283377; fax: +55 11 26615538.
E-mail address: eduardo.adam@incor.usp.br (E.L. Adam).
http://dx.doi.org/10.1016/j.ijid.2014.10.023
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).After the subsequent division of the NVS into different genera,
their most recent classiﬁcation was proposed by Collins and
Lawson in 2000 based on 16S rRNA gene sequencing, as follows:
Granulicatella genus, comprising Granulicatella adiacens, Granuli-
catella elegans, and Granulicatella balaenopterae; and Abiotrophia
genus, comprising solely Abiotrophia defectiva.2
Although more than 100 cases of IE caused by NVS have been
reported to date, we found only 25 cases of IE caused speciﬁcally by
Granulicatella sp since their division into the different genera and
species (Table 1).3–21 In the present article, we report four cases of
IE caused by Granulicatella species from our institution and provide
a brief review of the literature.
2. Case reports
2.1. Case 1
A 31-year-old male presented with a history of fever, fatigue,
and lower extremity edema of 15 days duration. The patientciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Cases of Granulicatella spp endocarditis reported to date
Reference Age, years Sex Valve Vegetation
size (mm)
Complications Antibiotics Valve surgery Outcome
[3] 38 NR Aortic NR NR PT, VAN, GEN Yes Survived
[4] 71 F Aortic (prosthetic) NR None PEN, GEN Yes Survived
[5] 29 M Aortic 14 Heart failure AMOX, GEN Yes Survived
[6] 68 M Pacemaker lead NR Osteomyelitis PEN, GEN, RIF No Survived
[7] 57 M No vegetation No vegetation CNS embolism AMP, GEN No Survived
[8] 85 M NR NR NR NR NR Died
[9] 53 F NR NR NR PEN, GEN Yes Survived
[10] 18 M Pulmonic (prosthetic) NR None VAN, GEN, RIF No Survived
[11] 77 F Aortic NR None VAN, AMP, GEN No Survived
[12] 43 M Aortic (prosthetic) NR Abscess PEN, GEN No Survived
[13] 18 F Mitral 16 Heart failure PEN, GEN Yes Survived
[13] 61 M Mitral and tricuspid 20 Heart failure PEN, GEN Yes Survived
[13] 30 M Mitral 11 CNS embolism PEN, GEN, CEF Yes Survived
[13] 28 F Mitral and aortic 13 Heart failure, peripheral embolism PEN, GEN, TEI, VAN Yes Survived
[14] 47 M Mitral 15 CNS embolism NR Yes Survived
[15] 31 M Mitral 10 CNS embolism OXA, GEN Yes Survived
[16] 71 M Mitral 20 Peripheral embolism AMP, GEN No Survived
[17] 81 M Mitral 18 Heart failure AMP, GEN No Survived
[18] 58 M Mitral NR None VAN, GEN No Survived
[18] 63 M Mitral and aortic NR Heart failure AMOX, GEN Yes Survived
[18] 38 F Tricuspid NR None AMOX, GEN No Survived
[18] 63 F Mitral and tricuspid NR None AMOX, GEN No Died
[19] 40 M Aortic 15 Abscess, heart failure VAN, AMP, GEN Yes Survived
[20] 32 F Tricuspid NR None LEV, PEN No Survived
[21] 86 M Aortic (prosthetic) NR None DAP, CEF No Died
This report 31 M Aortic 21 Abscess, ﬁstula CEF, OXA, GEN, TEI Yes Survived
This report 64 M Aortic 26 Heart failure CEF, OXA, GEN, TEI, VAN Yes Died
This report 75 M Aortic 19 CNS and spleen embolism CEF, PEN, GEN No Died
This report 59 F Aortic 8 Kidney and spleen embolism CEF, GEN, VAN Yes Survived
F, female; M, male; NR, not reported; CNS, central nervous system; PT, piperacillin–tazobactam; VAN, vancomycin; GEN, gentamicin; PEN, penicillin; AMOX, amoxicillin; RIF,
rifampin; AMP, ampicillin; CEF, ceftriaxone; TEI, teicoplanin; OXA, oxacillin; LEV, levoﬂoxacin; DAP, daptomycin.
E.L. Adam et al. / International Journal of Infectious Diseases 31 (2015) 56–58 57reported an unintentional 6-kg weight loss in the preceding
months. An echocardiogram showed a bicuspid aortic valve with
severe regurgitation and a 21-mm mobile vegetation. There was a
cavity suggestive of abscess formation in the mitro-aortic region
and a ﬁstula from the aorta to the left ventricle. Ceftriaxone,
oxacillin, and gentamicin were started. Surgery was performed for
correction of the local complications and valve replacement. After
identiﬁcation of Granulicatella sp in blood cultures, the antibiotic
regimen was changed to teicoplanin and gentamicin. The patient
was discharged home after 4 weeks of combined antibiotic
therapy.
2.2. Case 2
A 64-year-old male with a past medical history of diabetes,
obesity, and two coronary artery bypass surgeries was admitted for
evaluation of effort-induced dyspnea in the 30 days prior to
hospital presentation. The patient reported a weight loss of 25 kg
in the past 6 months. Physical examination showed signs of
pulmonary edema and poor dental hygiene. An echocardiogram
revealed two vegetations in the aortic valve and moderate valve
regurgitation. The initial empiric treatment for the IE was
ceftriaxone, oxacillin, and gentamicin. On the seventh day of
antibiotic therapy, the patient developed cardiogenic shock,
requiring emergency valve replacement surgery. G. adiacens was
identiﬁed in six blood cultures. Postoperatively, the antibiotic
regimen was changed to teicoplanin and maintained for 6 weeks.
The patient developed acute renal failure requiring hemodialysis
and multiple hospital-acquired infections, which were treated
with vancomycin, meropenem, polymyxin, and ﬂuconazole. He
progressed to refractory septic shock and died 5 months after the
surgery.2.3. Case 3
A previously hypertensive 75-year-old male was admitted for
investigation of weight loss and fatigue that had started after an
ischemic stroke 3 months before. His laboratory examinations
showed anemia, acute renal failure, and hematuria with dysmorphic
features. An echocardiogram showed severe aortic regurgitation
along with a 19-mm vegetation, and blood cultures were positive for
G. adiacens in two samples. Penicillin and gentamicin were initiated.
The patient developed embolization to the spleen, seizures, and
hemodynamic instability, leading to death 3 weeks later.
2.4. Case 4
A 59-year-old female, with a prior history of hypothyroidism
and dyslipidemia, reported fever and a 5-kg weight loss over a 5-
month period. Two weeks prior to admission, she had developed
left abdominal pain, lower extremity edema, and petechiae.
Abdominal computed tomography showed embolization to the
spleen and left kidney. An echocardiogram identiﬁed a bicuspid
aortic valve with severe regurgitation and a vegetation measuring
8 mm in diameter. Six blood cultures revealed Granulicatella
spp. After 2 weeks of treatment with ceftriaxone and gentamicin,
the fever recurred and an echocardiogram showed an increase in
the vegetation size to 12 mm. Valve replacement surgery was
performed. The patient received treatment with vancomycin and
gentamicin for 30 days and was discharged home asymptomatic.
3. Discussion
A subacute or even chronic presentation of IE caused by
Granulicatella sp has most often been described in the literature.
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constitutional symptoms such as weight loss, anorexia, and fever,
followed later by heart failure or embolism.
When analyzing all cases, we observed that the aortic valve was
affected in 44% (13/29) of patients, the mitral valve in 38% (11/29),
and the tricuspid valve in 13% (4/29). Prosthetic valve endocarditis
accounted for 13% (4/29) of cases. Multivalvular involvement was
also observed in 13% (4/29) of patients.
Endocarditis caused by Granulicatella sp has been associated
with adverse outcomes. Analyzing the 25 previously reported
cases together with our four, we found a mortality rate of 17% (5/
29). When information was available, we found an incidence of
heart failure of 30% (8/26). Embolism developed in 30% of patients
(8/26) and perivalvular abscess in 11% (3/26). Our four patients
developed at least one complication related to IE.
A vegetation length greater than 15 mm is recognized as a
strong predictor of embolic events and death in patients with IE in
the ﬁrst year after diagnosis.22 At least three of our patients
fulﬁlled this criterion and showed vegetations of 19 to 26 mm.
When a vegetation was found, the mean length observed in the
literature was 16 mm.
At our institution, the Bactec (BD Becton Dickinson) and VITEK 2
(bioMe´rieux) systems were used for culture and identiﬁcation. A
recent review of 23 cases of IE caused by NVS, including
Granulicatella species, showed rates of sensitivity to penicillin
reaching 78%.19 A phenomenon of penicillin tolerance has been
described with NVS, in which the minimum bactericidal concen-
tration (MBC) exceeds the minimum inhibitory concentration
(MIC) by over 32-fold, leading to a slower antibiotic effect in vivo
and possibly to a worse clinical response.23 Also, the relative
difﬁculty in identiﬁcation in blood cultures due to their nutritional
requirements could possibly lead to delayed initiation of the
appropriate antibiotic regimen and treatment failure.
In 85% of cases (23/27) the antibiotic regimen included a
penicillin or one of its derivatives plus gentamicin. Current
guidelines recommend that IE caused by Granulicatella sp should
be treated with antibiotics used for enterococcal IE. The
American Heart Association guidelines published in 2005 sug-
gest ampicillin or penicillin G plus gentamicin for 4 to 6 weeks or
vancomycin as an alternative regimen.24 The European Society of
Cardiology 2009 guidelines suggest penicillin G, ceftriaxone, or
vancomycin for 6 weeks, combined with an aminoglycoside for
at least the ﬁrst 2 weeks in the treatment of IE caused by NVS.25
In three of the four cases from our institution, the clinical course
was unfavorable despite the administration of the recommended
antibiotic regimens. The second patient, initially treated with
ceftriaxone, gentamicin, and oxacillin, developed cardiogenic
shock on the seventh day of treatment, with partial recovery
after cardiac surgery and the use of teicoplanin and vancomycin.
The third patient was treated with penicillin plus gentamicin
and died during treatment. The fourth patient, initially managed
with ceftriaxone and gentamicin, showed an increase in
vegetation size and fever after 2 weeks of therapy, requiring
cardiac surgery and a change of antibiotics to vancomycin and
gentamicin.
Endocarditis due to Granulicatella spp is a rare and severe
condition. Both the difﬁculty in isolation of the bacteria in blood
cultures and the undesirable treatment response highlights the
importance of this diagnosis. Considering the rarity of the
condition, the analysis of reported cases like ours is of paramount
importance.Conﬂict of interest: All authors report no conﬂicts.
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